Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study.
Inflammatory mammary carcinoma (IMC) is the most aggressive spontaneous type of mammary malignant tumor both in women and dogs. Latest studies in dogs indicate that different endocrine mechanisms seem to be involved in inflammatory carcinomas (IMCs). The aim of the present study was to characterize the steroid hormone profile of inflammatory carcinoma, and to compare it with mammary dysplasias, benign tumors and other malignant tumors. Eighty-six mammary samples (10 normal mammary tissue, 21 dysplasias, 26 benign, 22 malignant, and 7 IMC) from 30 female dogs were used. Hormone levels of progesterone (P4), 17beta-estradiol (E2), androstenedione (A4), dehydroepiandrosterone (DHEA), and estrone sulphate (E1SO4) in tissue homogenates were measured by enzyme immunoassays (EIAs) techniques, previously validated for this species. IMC displayed the following steroid profile: P4: 13.80+/-0.56 microg/g; E2: 675.19+/-33.00 ng/g; A4: 631.73+/-70.73 microg/g; DHEA: 702.22+/-89.93 microg/g, and E1SO4: 2.84+/-0.32 mg/g. All of these hormones were significantly higher (P<0.001) compared with the hormone steroid profile determined for malignant, benign, dysplasias, and normal mammary tissue. The most relevant finding was the increased levels, two or three times, of both DHEA and E1SO4 in IMC respect to other groups (P<0.001). These results, together with the highest immunohistochemical expression of P450scc found in IMC, suggest the hypothesis that an autocrine mechanism could be especially involved in the development of canine inflammatory carcinoma.
Peña
L
L
Department of Animal Pathology II, Veterinary Teaching Hospital, School of Veterinary Medicine, University Complutense of Madrid, Spain.
Silván
G
G
Pérez-Alenza
M D
MD
Nieto
A
A
Illera
J C
JC
D000735:Androstenedione / Q000096:biosynthesis; D000818:Animals; D002277:Carcinoma / Q000378:metabolism*; D003687:Dehydroepiandrosterone / Q000096:biosynthesis; D004285:Dogs; D004958:Estradiol / Q000096:biosynthesis; D004970:Estrone / Q000031:analogs & derivatives* / Q000096:biosynthesis; D005260:Female; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D007249:Inflammation; D015674:Mammary Neoplasms, Animal / Q000378:metabolism*; D011374:Progesterone / Q000096:biosynthesis
D004970:Estrone; D000735:Androstenedione; D003687:Dehydroepiandrosterone; D011374:Progesterone; D004958:Estradiol; C017296:estrone sulfate